Biowave Corporation to Present at Medtech Insight's ``Investment In Innovation'' Boston Conference.

BOSTON -- Biowave Corporation has announced that its President & CEO, Bradford Siff, will be presenting at 9:30 a.m. on Monday, October 10th, at Medtech Insight's "Investment In Innovation (In3) BOSTON: A Preview of Early-Stage Medical Technology Companies" Conference, taking place October 10-11, 2005, at The Westin Copley Place Hotel in Boston, MA.

Biowave Corporation is a minimally invasive neuromodulation pain therapy company whose major goal is to help physicians and surgeons manage their patients' pain and reduce or eliminate the use of opiates, NSAIDs and their associated side effects. The company's Deepwave(R) and Homewave(R) devices send an electronic signal into deep tissue in the body, blocking the transmission of pain. Deepwave(R) and Homewave(R) devices are currently being used for investigational use in IRB approved clinical studies under FDA guidelines to treat musculoskeletal pain that is chronic, acute or post-operative in nature and located in the low back, joints and extremities. Clinical studies have shown that following a 20-30 minute treatment, benefits include up to an immediate 80% average reduction in pain and a significant increase in range of motion and mobility, all of which last for up to 48 hours post treatment, without the side effects that are common to drugs, surgery and implanted devices.

Biowave signed a license agreement in June 2005 with a major Japanese medical device company for manufacturing and marketing in Japan, China and several smaller Asian countries. Additionally, Biowave's Japanese partner recently received Ministry of Health approval in Japan for its neuromodulation pain therapy device based on Biowave's technology.

In the U.S., Biowave filed its first 510(k) application with the FDA in August 2005 on its Deepwave Neuromodulation Pain Therapy Device and anticipates marketing clearance before year end.

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. To register for the "Investment In Innovation Boston" conference or for more information on Medtech Insight, please call Kristy Grimes at 480-985-9512, e-mail [e-mail], or visit www.medtechinsight.com.